{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:19:02Z","timestamp":1771665542902,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,16]]},"DOI":"10.7759\/cureus.60422","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T12:17:11Z","timestamp":1715861831000},"source":"Crossref","is-referenced-by-count":3,"title":["Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults"],"prefix":"10.7759","author":[{"given":"Taira","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riichi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Tokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kayashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52502.x","article-title":"What constitutes normal hemoglobin concentration in community-dwelling disabled older women?","volume":"52","author":"Chaves PH","year":"2004","unstructured":"Chaves PH, Xue QL, Guralnik JM, Ferrucci L, Volpato S, Fried LP. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc. 2004, 52:1811-6. 10.1111\/j.1532-5415.2004.52502.x","journal-title":"J Am Geriatr Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz T","year":"2011","unstructured":"Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011, 117:4425-33. 10.1182\/blood-2011-01-258467","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth E","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, et al.. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004, 306:2090-3. 10.1126\/science.1104742","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.017764","article-title":"Hepcidin revisited, disulfide connectivity, dynamics, and structure","volume":"284","author":"Jordan JB","year":"2009","unstructured":"Jordan JB, Poppe L, Haniu M, et al.. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem. 2009, 284:24155-67. 10.1074\/jbc.M109.017764","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.64.s87.7.x","article-title":"Erythropoietin should be part of congestive heart failure management","volume":"64","author":"Silverberg DS","year":"2003","unstructured":"Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A. Erythropoietin should be part of congestive heart failure management. Kidney Int Suppl. 2003, 64:S40-7. 10.1046\/j.1523-1755.64.s87.7.x","journal-title":"Kidney Int Suppl"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.10505","article-title":"Hepcidin and its potential clinical utility","volume":"39","author":"Miseta A","year":"2015","unstructured":"Miseta A, Nagy J, Nagy T, Po\u00f3r VS, Fekete Z, Sipos K. Hepcidin and its potential clinical utility. Cell Biol Int. 2015, 39:1191-202. 10.1002\/cbin.10505","journal-title":"Cell Biol Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23354","article-title":"Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia","volume":"88","author":"Bregman DB","year":"2013","unstructured":"Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol. 2013, 88:97-101. 10.1002\/ajh.23354","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.1","article-title":"Iron and hepcidin: a story of recycling and balance","volume":"2013","author":"Camaschella C","year":"2013","unstructured":"Camaschella C. Iron and hepcidin: a story of recycling and balance. Hematology Am Soc Hematol Educ Program. 2013, 2013:1-8. 10.1182\/asheducation-2013.1.1","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100651","article-title":"Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females","volume":"31","author":"Yazawa H","year":"2020","unstructured":"Yazawa H, Fukuda T, Kaneda H, et al.. Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females. Int J Cardiol Heart Vasc. 2020, 31:100651. 10.1016\/j.ijcha.2020.100651","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno T","year":"2007","unstructured":"Tanno T, Bhanu NV, Oneal PA, et al.. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007, 13:1096-101. 10.1038\/nm1629","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07961.x","article-title":"Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia","volume":"148","author":"Theurl I","year":"2010","unstructured":"Theurl I, Finkenstedt A, Schroll A, et al.. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol. 2010, 148:449-55. 10.1111\/j.1365-2141.2009.07961.x","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.09.040","article-title":"Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure","volume":"46","author":"Przyby\u0142owski P","year":"2014","unstructured":"Przyby\u0142owski P, Wasilewski G, Bachorzewska-Gajewska H, Golabek K, Dobrzycki S, Ma\u0142yszko J. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure. Transplant Proc. 2014, 46:2852-5. 10.1016\/j.transproceed.2014.09.040","journal-title":"Transplant Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101576","article-title":"Growth differentiation factor-15 (GDF-15) is a biomarker of muscle wasting and renal dysfunction in preoperative cardiovascular surgery patients","volume":"8","author":"Nakajima T","year":"2019","unstructured":"Nakajima T, Shibasaki I, Sawaguchi T, et al.. Growth differentiation factor-15 (GDF-15) is a biomarker of muscle wasting and renal dysfunction in preoperative cardiovascular surgery patients. J Clin Med. 2019, 8:1576. 10.3390\/jcm8101576","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17814-z","article-title":"Short Physical Performance Battery for cardiovascular disease inpatients: implications for critical factors and sarcopenia","volume":"7","author":"Yasuda T","year":"2017","unstructured":"Yasuda T, Nakajima T, Sawaguchi T, et al.. Short Physical Performance Battery for cardiovascular disease inpatients: implications for critical factors and sarcopenia. Sci Rep. 2017, 7:17425. 10.1038\/s41598-017-17814-z","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia","volume":"15","author":"Chen LK","year":"2014","unstructured":"Chen LK, Liu LK, Woo J, et al.. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014, 15:95-101. 10.1016\/j.jamda.2013.11.025","journal-title":"J Am Med Dir Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.03.017","article-title":"Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT","volume":"15","author":"Ross SL","year":"2012","unstructured":"Ross SL, Tran L, Winters A, et al.. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 2012, 15:905-17. 10.1016\/j.cmet.2012.03.017","journal-title":"Cell Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.025585","article-title":"Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages","volume":"95","author":"Beaumont C","year":"2010","unstructured":"Beaumont C. Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages. Haematologica. 2010, 95:1233-6. 10.3324\/haematol.2010.025585","journal-title":"Haematologica"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2008.08.004","article-title":"Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways","volume":"1784","author":"Kartikasari AE","year":"2008","unstructured":"Kartikasari AE, Roelofs R, Schaeps RM, Kemna EH, Peters WH, Swinkels DW, Tjalsma H. Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways. Biochim Biophys Acta. 2008, 1784:2029-37. 10.1016\/j.bbapap.2008.08.004","journal-title":"Biochim Biophys Acta"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2010.08.005","article-title":"Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines","volume":"1800","author":"Zhang X","year":"2010","unstructured":"Zhang X, Rovin BH. Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta. 2010, 1800:1262-7. 10.1016\/j.bbagen.2010.08.005","journal-title":"Biochim Biophys Acta"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini G","year":"2022","unstructured":"Masini G, Graham FJ, Pellicori P, et al.. Criteria for iron deficiency in patients with heart failure. J Am Coll Cardiol. 2022, 79:341-51. 10.1016\/j.jacc.2021.11.039","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg N","year":"2018","unstructured":"Grote Beverborg N, Klip IT, Meijers WC, et al.. Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail. 2018, 11:e004519. 10.1161\/CIRCHEARTFAILURE.117.004519","journal-title":"Circ Heart Fail"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab082","article-title":"The struggle towards a universal definition of heart failure-how to proceed?","volume":"42","author":"Cleland JG","year":"2021","unstructured":"Cleland JG, Pfeffer MA, Clark AL, et al.. The struggle towards a universal definition of heart failure-how to proceed?. Eur Heart J. 2021, 42:2331-43. 10.1093\/eurheartj\/ehab082","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss G","year":"2005","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005, 352:1011-23. 10.1056\/NEJMra041809","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/03009734.2018.1460427","article-title":"Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact","volume":"123","author":"Doerstling S","year":"2018","unstructured":"Doerstling S, Hedberg P, \u00d6hrvik J, Leppert J, Henriksen E. Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact. Ups J Med Sci. 2018, 123:86-93. 10.1080\/03009734.2018.1460427","journal-title":"Ups J Med Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.979740","article-title":"Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study","volume":"123","author":"Daniels LB","year":"2011","unstructured":"Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation. 2011, 123:2101-10. 10.1161\/CIRCULATIONAHA.110.979740","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-023-01505-9","article-title":"GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease","volume":"49","author":"Farag NM","year":"2023","unstructured":"Farag NM, Mousa M, Elsayed E, Ismeil A. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease. Ital J Pediatr. 2023, 49:106. 10.1186\/s13052-023-01505-9","journal-title":"Ital J Pediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000498959","article-title":"Association between plasma levels of growth differentiation factor-15 and renal function in the elderly: Korean frailty and aging cohort study","volume":"44","author":"Kim JS","year":"2019","unstructured":"Kim JS, Kim S, Won CW, Jeong KH. Association between plasma levels of growth differentiation factor-15 and renal function in the elderly: Korean frailty and aging cohort study. Kidney Blood Press Res. 2019, 44:405-14. 10.1159\/000498959","journal-title":"Kidney Blood Press Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1278-z","article-title":"GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients","volume":"48","author":"Lukaszyk E","year":"2016","unstructured":"Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients. Int Urol Nephrol. 2016, 48:839-44. 10.1007\/s11255-016-1278-z","journal-title":"Int Urol Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1240843","article-title":"GDF-15 and hepcidin levels in nonanemic patients with impaired glucose tolerance","volume":"2016","author":"Yalcin MM","year":"2016","unstructured":"Yalcin MM, Altinova AE, Akturk M, et al.. GDF-15 and hepcidin levels in nonanemic patients with impaired glucose tolerance. J Diabetes Res. 2016, 2016:1240843. 10.1155\/2016\/1240843","journal-title":"J Diabetes Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.320","article-title":"Lack of the bone morphogenetic protein BMP6 induces massive iron overload","volume":"41","author":"Meynard D","year":"2009","unstructured":"Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009, 41:478-81. 10.1038\/ng.320","journal-title":"Nat Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/254171-physiological-role-of-serum-growth-differentiation-factor-15-gdf-15-level-and-iron-metabolism-in-community-dwelling-older-adults","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T12:17:15Z","timestamp":1715861835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/254171-physiological-role-of-serum-growth-differentiation-factor-15-gdf-15-level-and-iron-metabolism-in-community-dwelling-older-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.60422","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}